Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530705) titled 'Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism' on April 1.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Hypoparathyroidism
Intervention:
Drug: Single subcutaneous injection
Recruitment Status: Recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: November 17, 2025
Target Sample Size: 15
Countries of Recruitment:
China
To know more, visit https://clinicaltr...